Viewing Study NCT06625333


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2025-12-31 @ 2:15 PM
Study NCT ID: NCT06625333
Status: RECRUITING
Last Update Posted: 2025-06-13
First Post: 2024-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HR+HER2- Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HR+HER2- advanced breast cancer, ribociclib, elderly patients View